Prevalence and predictive factors of non-alcoholic steatohepatitis (NASH) in morbidly obese patients undergoing bariatric surgery

被引:51
作者
Harnois, F
Msika, S
Sabaté, JM
Mechler, C
Jouet, P
Barge, J
Coffin, B
机构
[1] Hop Louis Mourier, Serv Hepatogastroenterol, AP HP, F-92701 Colombes, France
[2] Hop Louis Mourier, Serv Chirurg Viscerale, AP HP, F-92701 Colombes, France
[3] Hop Louis Mourier, Lab Anatomopathol, AP HP, F-92701 Colombes, France
关键词
morbid obesity; liver biopsy; steatohepatitis; gastric banding; gastric bypass;
D O I
10.1381/096089206775565122
中图分类号
R61 [外科手术学];
学科分类号
摘要
Background: In patients with morbid obesity selected for bariatric surgery, previous studies have shown a prevalence of NASH varying from 2.6% to 91%. The prevalence of NASH and extensive fibrosis were studied in a prospective cohort of patients with morbid obesity requiring bariatric surgery, to identify predictive factors of NASH. Methods: From July 01 to Sept 02, every patient requiring bariatric surgery had a liver biopsy. The diagnosis of NASH was established using Lee's criteria. Results: 92 patients (85 women, age 38 +/- SEM 11 years) were analyzed. Mean BMI was 45.7 +/- 5.1 kg/m(2). 35 patients had lobular inflammation. 9 patients had steatosis associated with lobular necrotic and inflammatory foci and ballooning degeneration or pericellular fibrosis. No cirrhosis or extensive fibrosis was evidenced. The prevalence of NASH in this population was 9.8%. Waist/hips ratio and BMI were independent predictors of lobular inflammation, but only BMI was an independent factor of NASH in multivariate analysis. Conclusion: In this prospective cohort of patients at bariatric surgery, the prevalence of NASH was 9.8%. BMI was the only predictive factor for NASH.
引用
收藏
页码:183 / 188
页数:6
相关论文
共 28 条
[1]   Portal fibrosis and hepatic steatosis in morbidly obese subjects: A spectrum of nonalcoholic fatty liver disease [J].
Abrams, GA ;
Kunde, SS ;
Lazenby, AJ ;
Clements, RH .
HEPATOLOGY, 2004, 40 (02) :475-483
[2]   Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis [J].
Angulo, P ;
Keach, JC ;
Batts, KP ;
Lindor, KD .
HEPATOLOGY, 1999, 30 (06) :1356-1362
[3]  
Ascaso Juan F, 2003, Eur J Intern Med, V14, P101, DOI 10.1016/S0953-6205(03)00022-0
[4]   Prevalence and predictors of asymptomatic liver disease in patients undergoing gastric bypass surgery [J].
Beymer, C ;
Kowdley, KV ;
Larson, A ;
Edmonson, P ;
Dellinger, EP ;
Flum, DR .
ARCHIVES OF SURGERY, 2003, 138 (11) :1240-1244
[5]   Nonalcoholic steatohepatitis: A proposal for grading and staging the histological lesions [J].
Brunt, EM ;
Janney, CG ;
Di Bisceglie, AM ;
Neuschwander-Tetri, BA ;
Bacon, BR .
AMERICAN JOURNAL OF GASTROENTEROLOGY, 1999, 94 (09) :2467-2474
[6]  
Brunt EM, 2004, SEMIN LIVER DIS, V24, P3
[7]   Expanding the natural history from cryptogenic cirrhosis to of nonalcoholic steatohepatitis: Hepatocellular carcinoma [J].
Bugianesi, E ;
Leone, N ;
Vanni, E ;
Marchesini, G ;
Brunello, F ;
Carucci, P ;
Musso, A ;
De Paolis, P ;
Capussotti, L ;
Salizzoni, M ;
Rizzetto, M .
GASTROENTEROLOGY, 2002, 123 (01) :134-140
[8]   New classification and criteria for diagnosis of diabetes mellitus - Position statement from the Australian Diabetes Society, New Zealand Society for the Study of Diabetes, Royal College of Pathologists of Australasia and Australasian Association of Clinical Biochemists [J].
Colman, PG ;
Thomas, DW ;
Zimmet, PZ ;
Welborn, TA ;
Garcia-Webb, P ;
Moore, MP .
MEDICAL JOURNAL OF AUSTRALIA, 1999, 170 (08) :375-378
[9]   Are there predictive factors of severe liver fibrosis in morbidly obese patients with non-alcoholic steatohepatitis? [J].
Crespo, J ;
Fernández-Gil, P ;
Hernández-Guerra, M ;
Cayón, A ;
Mayorga, M ;
Domínguez-Diez, A ;
Fernández-Escalante, JC ;
Pons-Romero, F .
OBESITY SURGERY, 2001, 11 (03) :254-257
[10]   Nonalcoholic fatty liver disease: Predictors of nonalcoholic steatohepatitis and liver fibrosis in the severely obese [J].
Dixon, JB ;
Bhathal, PS ;
O'Brien, PE .
GASTROENTEROLOGY, 2001, 121 (01) :91-100